{"ok":true,"entry":{"slug":"triamcinolone","kind":"medication","name":"triamcinolone","aliases":["Kenacort","Aristocort"],"brands_sg":["Oracort E","Oral Aid","Keno","Oramedy","Shincort"],"class":"corticosteroid","tags":["skin"],"use_for":"prescribed for inflamed, itchy steroid-responsive skin","use_after":"fda: the 0.1% ointment goes on two to three times daily","use_duration":null,"take_with":"a thin film on the affected area only (fda ointment)","pros":["fda: a topical form and a long-acting injection exist","hsa: two sg oral pastes are pharmacy-only, not rx","fda topical: local reactions reported infrequently"],"cons":["fda: skin thinning, striae and hypopigmentation","fda injection: anaphylaxis including death reported","fda: occlusive dressings raise local reaction rates"],"dose_note":"the us fda label for triamcinolone acetonide ointment describes a thin film of the 0.025% strength on the affected area 'two to four times daily' and of the 0.1% or 0.5% strength 'two to three times daily' — a frequency ceiling, not a milligram one; that topical label states no maximum daily milligram dose. the us label for triamcinolone acetonide injectable suspension says the initial dose 'may vary from 2.5 mg to 100 mg per day', that systemic dosing is 'usually adjusted within the range of 40 mg to 80 mg', and carries as its highest daily figure, for acute multiple-sclerosis exacerbations, 'daily doses of 160 mg of triamcinolone for a week followed by 64 mg every other day for one month'. singapore registers pastes, creams, injections and a nasal spray — separate forms with separate ceilings. in singapore the prescriber sets the dose.","dosage":null,"ul_status":null,"sg_class":"prescription-only","cautions":["fda: hypersensitivity to any component of the product","fda injection: not used in idiopathic thrombocytopenic purpura","fda injection: contains benzyl alcohol — a risk in neonates","fda: adrenal suppression can persist for a year afterwards"],"clashes":[],"sources":[{"id":"hsa_register","url":"https://data.gov.sg/datasets/d_767279312753558cbf19d48344577084/view","label":"HSA — Listing of Registered Therapeutic Products (data.gov.sg open dataset, 5,511 rows, cached in full and filtered locally)","quote":"13 triamcinolone rows: 11 read 'Prescription Only' and 2 read 'Pharmacy Only' — ORACORT E DENTAL PASTE (SIN04682P) and KENO ORAL PASTE 1 mg/g (SIN11853P). Forms: paste, cream, injection 10 and 40 mg/ml, nasal spray 55 mcg/dose.","accessed":"2026-08-27"},{"id":"fda_tri_top_ind","url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:%22triamcinolone%20acetonide%22&limit=5","label":"US FDA label — Triamcinolone Acetonide Ointment (topical), Indications and Usage, via openFDA drug/label.json","quote":"Triamcinolone Acetonide Ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.","accessed":"2026-08-27"},{"id":"fda_tri_top_dose","url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:%22triamcinolone%20acetonide%22&limit=5","label":"US FDA label — Triamcinolone Acetonide Ointment (topical), Dosage and Administration, via openFDA drug/label.json","quote":"Apply a thin film of Triamcinolone Acetonide Ointment 0.025% to the affected area two to four times daily. Apply a thin film of the 0.1% or the 0.5% … two to three times daily.","accessed":"2026-08-27"},{"id":"fda_tri_top_ae","url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:%22triamcinolone%20acetonide%22&limit=5","label":"US FDA label — Triamcinolone Acetonide Ointment (topical), Adverse Reactions, via openFDA drug/label.json","quote":"The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings … burning, itching, irritation, dryness … skin atrophy, striae … hypopigmentation","accessed":"2026-08-27"},{"id":"fda_tri_inj_dose","url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:%22triamcinolone%20acetonide%22&limit=5","label":"US FDA label — Triamcinolone Acetonide Injectable Suspension, Dosage and Administration, via openFDA drug/label.json","quote":"The initial dose of triamcinolone acetonide injectable suspension may vary from 2.5 mg to 100 mg per day depending on the specific disease entity being treated … Dosage is usually adjusted within the range of 40 mg to 80 mg","accessed":"2026-08-27"},{"id":"fda_tri_inj_dose_ms","url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:%22triamcinolone%20acetonide%22&limit=5","label":"US FDA label — Triamcinolone Acetonide Injectable Suspension, dosing in multiple sclerosis, via openFDA drug/label.json","quote":"In the treatment of acute exacerbations of multiple sclerosis, daily doses of 160 mg of triamcinolone for a week followed by 64 mg every other day for one month are recommended.","accessed":"2026-08-27"},{"id":"fda_tri_inj_ci","url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:%22triamcinolone%20acetonide%22&limit=5","label":"US FDA label — Triamcinolone Acetonide Injectable Suspension, Contraindications, via openFDA drug/label.json","quote":"Triamcinolone acetonide injectable suspension is contraindicated in patients who are hypersensitive to any components of this product … Intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura.","accessed":"2026-08-27"},{"id":"fda_tri_inj_warn","url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:%22triamcinolone%20acetonide%22&limit=5","label":"US FDA label — Triamcinolone Acetonide Injectable Suspension, Warnings, via openFDA drug/label.json","quote":"Cases of serious anaphylaxis, including death, have been reported … Exposure to excessive amounts of benzyl alcohol has been associated with toxicity … particularly in neonates … supportive dosage may be required … for a year afterwards","accessed":"2026-08-27"}],"brand_certs":null,"updated_at":"2026-08-29T16:16:33.302383+08:00"},"disclaimer":"kozen-x is not a medical device and does not give medical advice. it lists what published sources have written down. absence of a record is not the same as safe."}